← Human Trials & Peer-Reviewed Studies
[Minimally invasive surgery versus bilateral neck exploration for primary hyperparathyroidism: controlled prospective study. Role of intraoperative rapid parathyroid hormone assay and radiological preoperative detection of adenomas]
Plain-language guide to PMID 16491770 (2005): randomized controlled trial study of Parathyroid Hormone (PTH 1-84) in 15 patients, hyperparathyroidism.
Key Facts
- PMID
- 16491770
- Journal
- Recenti progressi in medicina
- Year
- 2005
- Study type
- Randomized Controlled Trial
- Authors
- Simonella G et al. (6 authors)
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial paper looks at Parathyroid Hormone (PTH 1-84) in the context of hyperparathyroidism.
Their purpose was to evaluate and compare the results of the 2 different surgical management in a follow-up period of observation.
Why It Was Studied
There is considerable controversy today concerning the most appropriate surgical approach for patients with primary hyperparathyroidism.
The standard surgical approach involves a bilateral neck exploration.
Who Took Part
The abstract describes 15 patients taking part.
PubMed indexes the participants as adults, middle-aged adults and older adults, women only.
How the Study Was Run
The design is described as randomized.
Random assignment meant chance, not the researchers, decided who got Parathyroid Hormone (PTH 1-84) and who got the comparison, which limits bias.
The first 10 were random selected to surgery; the successive 5 were assigned at group II.
What Was Measured
There is considerable controversy today concerning the most appropriate surgical approach for patients with primary hyperparathyroidism.
Topics PubMed links to this paper include Adenoma, Hyperparathyroidism, Italy, Minimally Invasive Surgical Procedures, Monitoring, Intraoperative, Parathyroid Hormone and Parathyroid Neoplasms.
What This Means in Plain Language
The paper is a randomized study of Parathyroid Hormone (PTH 1-84) in 15 patients in people with hyperparathyroidism.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
The publication is from 2005 (Recenti progressi in medicina), a journal based in Italy.
More context: the Parathyroid Hormone (PTH 1-84) compound page, Hyperparathyroidism research.
Our Notes on the Compound
Parathyroid Hormone (PTH 1-84): The 84-amino-acid hormone that raises blood calcium; full-length PTH (Natpara) has been used in hypoparathyroidism. Teriparatide is its 1-34 fragment.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.